Dr. Mark Linch

About Dr. Mark Linch

Dr. Mark Linch is a Medical Oncologist specialising in prostate cancer and bladder cancer.
He focuses on tailoring immunotherapy, hormonal treatment, and chemotherapy based on the molecular and clinical features of individual patients.
He is an Associate Professor at University College London (UCL) Cancer Institute.
He serves as an Honorary Consultant Medical Oncologist and Director of Innovation at The London Clinic.
Dr. Linch trained in medical oncology at the Royal Marsden Hospital (RMH), London.
In 2012, he was awarded a PhD in Cancer Cell Biology from UCL and the Cancer Research UK London Research Institute (LRI), now the Francis Crick Institute.
He continued post-doctoral studies at the LRI while working as a Consultant Medical Oncologist at RMH.
In 2014, he joined UCL to specialise in the clinical management and translational biology of prostate and bladder cancer.
His research focuses on the immune biology of prostate and bladder cancers to develop rational immunotherapy combinations, predictive biomarkers, and novel liquid biopsy strategies.
He is the chief investigator of several national and international combination immunotherapy trials in bladder and prostate cancer.

Conditions treated by Dr. Mark Linch

Prostate cancer
Bladder cancer
Advanced/metastatic prostate cancer
Non-muscle-invasive bladder cancer
Muscle-invasive bladder cancer

Area of Interest

Advanced therapeutics
Chemotherapy
Immunotherapy
Medical Oncology
Uro-oncology

Qualification

BSc (Hons), MBChB from Leeds University Medical School, Yorkshire, 2000
Diploma in Oncology and Cancer Biology from University of London, 2007
PhD in Cancer Cell Biology from University College London (UCL), 2011

Work Experiences

Medical Oncology Consultant, The Royal Marsden NHS Foundation Trust, 2012 – 2014
Medical Oncology Specialist Registrar, The Royal Marsden NHS Foundation Trust, 2004 – 2011

Global Team of Board Certified Surgeons and Medical Specialists
Written Second Opinion report delivered within 5 days
Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Mark Linch on our platform

Consult Online

CERTIFICATIONS (1)

Clinical Research Fellow, Cancer Research UK (CRUK) / London Research Institute, 2007 – 2011

MEMBERSHIPS (1)

RESEARCH PAPERS AND PUBLICATIONS (5)

Leone G, … Linch M. Nivolumab and ipilimumab for metastatic castration-resistant prostate cancer with an immunogenic signature: the multicentre, two-cohort, phase 2 NEPTUNES study. J Clin Oncol Jul 2025.
Dev H, Linch M, … Pacey S. Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer. Clin Cancer Res. Jun 2025.
Yu EY, Linch M,..de Bono JS. Pembrolizumab plus abiraterone acetate and prednisone in Patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results for KEYNOTE-365 Cohort D.
Eur Urol Oncol. Jun 2025; 8(3):641-651.
Craddock C,…Linch M,..Winter H. UK cancer vaccine advance – Recognising and realising opportunities. Camb Prism Precis Med. Jan 2025.

Share Your Experience about Dr. Mark Linch

Write Your Review

PROCEDURES

Chemotherapy
Hormonal Therapy
Prostate Cancer Treatment

FREQUENTLY ASKED QUESTIONS

Is Dr. Mark Linch doing teleconsultation on the MediGence platform?

Dr. Mark Linch is available to teleconsult on the MediGence platform.

How long is the consultation?

The consultation can last from 15 to 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.

How soon can the consultation be organised?

We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

Is a follow-up consultation included in the consultation price?

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

How do I share my medical record with the doctor for review?

The option to share your medical records is available between the steps of the form provided to you on the website.

Can I book my procedure with the doctor post-consultation?

Yes. If you are satisfied with the consultation, you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Can you get an estimate for the procedure?

Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about traveling to your medical destination.

FAQ's Related to Medical Oncologist

What does a medical oncologist do?

A medical oncologist diagnoses and treats cancer using drug-based therapies such as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. They also coordinate care with other specialists like surgeons and radiation oncologists.

When should I see a medical oncologist?

You should see one if you have a confirmed or suspected cancer diagnosis, recurrence of cancer, or need guidance on systemic treatment options.

What types of cancer do medical oncologists treat?

They treat all types of cancers, including renal cancer, bladder cancer, colorectal cancer, prostate cancer and blood cancer.

How does a medical oncologist decide on the best treatment?

They base decisions on your cancer type, stage, genetic profile, and overall health, often using precision medicine approaches.

Are treatments painful?

Drug treatments are usually not painful, though they may cause side effects like nausea, fatigue, or hair loss, which doctors help manage.

Can a medical oncologist help with palliative care?

Yes. They also manage symptoms, pain, and quality of life, especially for patients with advanced cancer.

How do medical oncologists monitor treatment progress?

Through blood tests, scans, and check-ups to see if the cancer is responding to treatment and to adjust therapies if needed.

Welcome To MediGence

Your Notifications